Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aufbau Holdings is a private Ireland-based biotechnology holding company developing diagnostic and therapeutic platforms focused on cancer and ophthalmic disease. The company describes itself as employing novel biology to build a portfolio for the detection, monitoring, and treatment of cancer, eye diseases, and other disorders. Its portfolio includes Aufbau Medical Innovations Ltd. and Sonder Medicine Inc. d/b/a Sonder Research X, which are focused on ophthalmic diagnostics, ocular drug delivery, and related therapeutic development. Publicly available information indicates the company remains at an early, preclinical/platform stage, with limited disclosure of named clinical assets or human-stage programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aufbau Holdings.